SENORES — Senores Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- IN₹55.97bn
- IN₹56.38bn
- IN₹6.33bn
Brief: Senores Pharmaceuticals Says U.S.FDA Completes Inspection At Unit's Vadodara Facility
Brief: Senores Pharmaceuticals Says To Incorporate Units In Mexico, Canada
Brief: Senores Pharmaceuticals Ltd June-Quarter Consol Net Profit 307.2 Million Rupees
Brief: Senores Pharmaceuticals March-Quarter Consol Net Profit 316.1 Million Rupees
Brief: Senores Pharmaceuticals Announces Strategic Joint Venture In United States
India's Senores Pharma rises on upbeat quarterly results, outlook
Brief: Senores Pharmaceuticals Dec-Quarter Consol Net Profit 316.6 Million Rupees
Brief: Senores Pharmaceuticals Board Approves Issuance Of Warrants Upto 950 Million Rupees
Brief: Senores Pharmaceuticals To Acquire Apnar Pharma
Brief: Senores Pharmaceuticals Receives Philippine FDA Approval For 10 Products
Brief: Senores Pharmaceuticals Invests $2 Million Through Rights Issue In US Unit
Brief: Senores Pharmaceuticals Says Havix Completes USFDA Inspection With 3 Observations
India's Senores Pharma hits record high on Q1 profit surge
India's Senores Pharma up on buying generic hypertension drug from Wockhardt
Brief: Senores Pharmaceuticals Acquires ANDA For Tramadol Tablets From APDM Pharmaceuticals
Brief: Senores Pharmaceuticals Acquires USFDA-Approved ANDA For Topiramate Tablets
India's Senores Pharma, Ventive Hospitality, Carraro India drop as lock-in periods expire
Brief: Senores Pharmaceuticals Says Investment Of $468,640 In SPI Through Rights Issue
Brief: Senores Pharmaceuticals Acquires 14 ANDAs From Dr. Reddy's Laboratories